1. Home
  2. NTRA vs NU Comparison

NTRA vs NU Comparison

Compare NTRA & NU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$378.07

Market Cap

56.7B

Sector

Health Care

ML Signal

N/A

Logo Nu Holdings Ltd.

NU

Nu Holdings Ltd.

N/A

Current Price

$11.65

Market Cap

61.8B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
NU
Founded
2003
2013
Country
United States
Brazil
Employees
N/A
N/A
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.7B
61.8B
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
NTRA
NU
Price
$378.07
$11.65
Analyst Decision
Strong Buy
Buy
Analyst Count
23
23
Target Price
★ $416.39
$18.80
AVG Volume (30 Days)
1.4M
★ 82.8M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 0.65
N/A
EPS
N/A
★ N/A
Revenue
★ $210,939,000.00
N/A
Revenue This Year
$26.22
$226.17
Revenue Next Year
$20.96
$23.95
P/E Ratio
★ N/A
$33.29
Revenue Growth
N/A
★ N/A
52 Week Low
$181.00
$11.20
52 Week High
$437.41
$18.98

Technical Indicators

Market Signals
Indicator
NTRA
NU
Relative Strength Index (RSI) 43.12 30.58
Support Level $187.64 N/A
Resistance Level $437.41 $14.60
Average True Range (ATR) 19.55 0.58
MACD -2.75 -0.39
Stochastic Oscillator 5.74 3.16

Price Performance

Historical Comparison
NTRA
NU

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About NU Nu Holdings Ltd.

Nu Holdings Ltd is a Brazilian financial technology firm that offers digital banking services. Its services include Retail credit, SME credit, Payments, Customer assets, Insurance brokerage, E-commerce marketplace, and Mobile virtual network operator. It operates in single operating segment and geographically it operates in Brazil, Mexico, and Other countries with the majority of revenue deriving from Brazil.

Share on Social Networks: